Literature DB >> 35346915

Reply to Letter to the Editor: "Fragmented QRS Pattern in Patients with COVID-19: Further Insights into Its Temporal and Mechanistic Features".

İbrahim Halil Özdemir1, Bülent Özlek2, Eda Özlek2.   

Abstract

Entities:  

Mesh:

Year:  2022        PMID: 35346915      PMCID: PMC9366425          DOI: 10.5152/AnatolJCardiol.2022.L4

Source DB:  PubMed          Journal:  Anatol J Cardiol        ISSN: 2149-2263            Impact factor:   1.475


× No keyword cloud information.
To the Editor, We have recently read with great interest the article entitled Fragmented QRS pattern in patients with COVID-19: Further insights into its temporal and mechanistic features. The paper is an invaluable mini-review on the possible pathophysiological mechanisms and clinical implications of fragmented QRS (f-QRS) in patients with novel coronavirus disease (COVID-19).[1] We thank the authors for their interest and thoughtful comments on our study.[2] We would like to answer 2 questions that the authors wonder about our paper. First, we agree with the authors that it is important to determine whether f-QRS is reversible or irreversible in order to have clearer evidences about long-term outcomes. However, our study was designed retrospectively. Therefore, we did not perform a prospective follow-up of survivors. Secondly, as the authors mentioned, coronary slow flow (CSF) may be an important indicator of hyperinflammation. On the other hand, there was no patient who underwent emergent coronary angiogram in our study population. Therefore, it was not possible to perform CSF analysis in patients with ST-segment depression on an electrocardiogram.
  2 in total

1.  Fragmented QRS is a marker of mortality in patients with severe COVID-19: A retrospective observational study.

Authors:  İbrahim Halil Özdemir; Bülent Özlek; Mehmet Burak Özen; Ramazan Gündüz; Nurullah Çetin; Eda Özlek; Bekir Sedat Yıldız; Hakan Tıkız
Journal:  Anatol J Cardiol       Date:  2021-11       Impact factor: 1.596

2.  Fragmented QRS Pattern in Patients with COVID-19: Further Insights into Its Temporal and Mechanistic Features.

Authors:  Gökay Taylan; Cihan Öztürk; Kenan Yalta
Journal:  Anatol J Cardiol       Date:  2022-03       Impact factor: 1.475

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.